Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
10/1996
10/30/1996CN1033143C Radiopharmaceutical formulations, their method of administration and process of preparation
10/29/1996US5569759 Water soluble texaphyrin metal complex preparation
10/29/1996US5569745 Peptide-Chelator conjugates
10/29/1996US5569447 Stannylated 3-quinuclidinyl benzilates and methods of preparing radiohalogenated derivatives
10/24/1996WO1996032968A1 Compounds for cancer imaging and therapy
10/24/1996WO1996032967A1 Hybrid magnetic resonance contrast agents
10/24/1996CA2215839A1 Compounds for cancer imaging and therapy
10/23/1996EP0738283A1 New polyaminocarboxylate chelators
10/23/1996EP0738158A1 Biological targeting agents
10/23/1996EP0558661B1 Polyazamacrocyclic compounds for complexation of metal ions
10/23/1996EP0422125B1 Platelet blocking peptides
10/23/1996CN1134159A Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparation contg. these compounds
10/23/1996CN1134158A N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions contg. these compounds
10/22/1996US5567687 Useful in photodynamic therapy and light-induced cleavage of a polymer of deoxyribonucleic acid
10/22/1996US5567408 YIGSR peptide radiopharmaceutical applications
10/22/1996CA2094974C Stable porfimer sodium compositions and methods for their manufacture
10/17/1996WO1996032419A1 Biodegradable polyacetal polymers and formation and use
10/17/1996WO1996032133A2 Conjugate for treating inflammatory, infectious and/or skin diseases
10/17/1996WO1996023526A3 Diagnostic imaging contrast agents with extended blood retention
10/17/1996DE19514088A1 Konjugat zur Behandlung von Entzünduns-, Infektions- und/oder Hauterkrankungen A conjugate for the treatment of Entzünduns-, infectious and / or skin diseases
10/16/1996EP0737220A1 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
10/16/1996EP0737207A1 Inhibitors of human plasmin derived from the kunitz domains
10/16/1996CN1033030C Preparation of macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
10/15/1996US5565552 Method of expanded porphyrin-oligonucleotide conjugate synthesis
10/15/1996US5565356 Hybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell lines
10/15/1996US5565215 Biodegradable injectable particles for imaging
10/15/1996US5565188 Therapeutiac or diagnostic agents having polyoxyalkylene glycol triblock polymers adsorbed on particle surfaces
10/10/1996WO1996031243A1 Ternary radiopharmaceutical complexes
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/08/1996US5563250 For diagnosis, therapy
10/08/1996US5562894 Complexes for magnetic resonance imaging contrast agents
10/08/1996US5562099 Polymeric microparticles containing agents for imaging
10/03/1996WO1996030056A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/03/1996WO1996030055A2 Radiolabeled peptides for diagnosis and therapy
10/03/1996WO1996030054A1 99mTc - LABELLED SEROTONIN RECEPTOR BINDING SUBSTANCES
10/03/1996WO1996024381A3 Liposomes containing contrast media for blood pool imaging
10/03/1996WO1994004702A3 Improved detection and therapy of lesions with biotin/avidin conjugates
10/03/1996CA2215833A1 Hydroxyalkyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
10/02/1996EP0735040A2 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
10/02/1996EP0734575A1 Apparatus and method for the preparation of a radiopharmaceutical formulation
10/02/1996EP0734385A1 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/01/1996US5561220 Technetium-99m labeled peptides for imaging inflammation
10/01/1996US5561043 Genetic engineering
10/01/1996US5560901 Radionuclide labelled particles useful for radiation synovectomy
09/1996
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029087A1 Methods for reduced renal uptake of antibody fragments
09/26/1996WO1995022544A3 Substituted 1,3,8-triaza-spiro(4,5)-decan-4-one derivatives useful as preliminary stages in the production of pharmaceuticals
09/26/1996CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof
09/25/1996EP0733374A2 Cyano-alpha-amino carboxylic acids, and their use in preparing labelled alpha-amino acids
09/25/1996EP0733206A1 Labelling of nucleic acid analogue-peptide chimerae
09/25/1996EP0733072A1 Antibody against carcinoembryonic antigen (cea)
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733060A1 Metal chelators
09/25/1996EP0732944A1 Labeled chemotactic peptides to image focal sites of infection or inflammation
09/25/1996EP0732943A1 Three-step pretargeting methods and compounds
09/25/1996EP0732942A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
09/25/1996EP0732939A1 Preparation and use of immunoconjugates
09/25/1996EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
09/25/1996CN1131962A Tris (isonitrile) copper (I) sulfates for preparing radionuclide
09/24/1996US5559214 Unsymmetrical complexing agents and targeting immunoreagents useful in thearpeutic and diagnostic compositions and methods
09/24/1996US5559207 Texaphyrin metal complex mediated ester hydrolysis
09/24/1996US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies
09/24/1996US5558852 Methods of treating melanomas and gliomas with monoclonal antibody Me1-14
09/19/1996WO1996028471A1 Modulators of amyloid aggregation
09/19/1996WO1996028190A1 Non-invasive imaging of gene transfer
09/18/1996EP0731713A1 Metal-ion chelates with acidic saccharides and glycosaminoglycans
09/17/1996US5556982 Metal radionuclide labeled proteins for diagnosis and therapy
09/17/1996US5556968 Polyazamacrocycle chelating agents with amide linkages
09/17/1996US5556939 TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
09/17/1996US5556609 Metal labled peptides for medical diagnosis of diseases
09/12/1996WO1996016677A3 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography
09/11/1996EP0730873A1 A radioactive patch/film and process for preparation thereof
09/11/1996EP0730872A1 Radioactive patch for curing a skin disease and manufacturing method thereof
09/11/1996EP0730871A1 Radioactive chitosan complex and the use thereof for radiation therapy
09/11/1996EP0730870A1 Radioactive chitosan complex and its macroaggregates for use in internal radiation therapy and their preparation method
09/11/1996EP0730586A1 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production
09/11/1996EP0730472A1 Immobilized labelling method
09/11/1996EP0534944B1 Antibodies specific for elam-1 and the use thereof
09/11/1996EP0521977B1 Contrast media
09/10/1996US5554752 Spiro fused piperidines capable of binding to a vesamicol receptor and having anticholinergic properties
09/10/1996US5554748 Adducts of macrocyclic chelants
09/10/1996US5554602 Labelling of hormones with rhenium and tecnetium
09/08/1996CA2152697A1 Radioactive patch for curing a skin disease and manufacturing method thereof
09/04/1996EP0458878B1 Monoclonal antibody to novel antigen associated with human tumors
09/03/1996US5552525 Radiodiagnostic reagents using peptides for detection of infections
09/03/1996US5552443 Treatment of psychosis, anxiety and as hypotensive agents
09/03/1996US5552293 Tumor antigen specific antibody
08/1996
08/29/1996WO1996026272A1 Prostate-specific membrane antigen and uses thereof
08/29/1996WO1996026180A1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals
08/29/1996WO1996025956A2 Individual medicament dosing conjugate
08/29/1996WO1996025947A2 Induction of e-selectin for targetting therapeutic agents
08/29/1996WO1996025921A1 Polyalkylene block copolymers as surface modifiers for nanoparticles
08/29/1996CA2213454A1 Dtpa derivatives substituted in a novel way, their metal complexes, pharmaceutical agents containing these complexes, their use in diagnosis and therapy, as well as process for the production of complexes and agents
08/29/1996CA2212846A1 Prostate-specific membrane antigen and uses thereof
08/28/1996EP0728019A1 Labelled diagnostic compositions and methods of their use
08/28/1996EP0727959A1 Diagnostic uses of hydrazinoadenosines
08/28/1996CN1129591A Intracorporal guiding treating agent for rheumatoid disease
08/27/1996US5550160 Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
08/27/1996US5550124 Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease